Gastrointestinal Pathology — MCQs

Gastrointestinal Pathology Indian Medical PG Practice Questions and MCQs

Question 211: Which of the following statements is not true regarding Menetrier's disease?

A. Diffuse foveolar cell hyperplasia
B. Overexpression of TGF-β (Correct Answer)
C. Protein losing enteropathy
D. Hypertrophy of rugal folds

Explanation: **Explanation:** Menetrier’s disease is a rare, acquired hypertrophic gastropathy characterized by the excessive secretion of **Transforming Growth Factor-alpha (TGF-α)**, not TGF-β. **1. Why Option B is the Correct Answer (The False Statement):** The pathogenesis of Menetrier’s disease involves the **overexpression of TGF-α**, which acts as a ligand for the **Epidermal Growth Factor Receptor (EGFR)**. This signaling pathway triggers the selective proliferation of mucous-secreting surface epithelial cells (foveolar cells) while inhibiting acid-producing parietal cells. TGF-β is generally involved in fibrosis and immune regulation, not the primary proliferative drive in this disease. **2. Analysis of Other Options:** * **Option A (Diffuse foveolar cell hyperplasia):** This is the hallmark histological feature. The gastric pits become elongated, corkscrew-shaped, and filled with mucus [1]. * **Option C (Protein-losing enteropathy):** The massive expansion of the surface epithelium and leakage through tight junctions lead to significant loss of albumin into the gastric lumen, resulting in **hypoalbuminemia** and peripheral edema. * **Option D (Hypertrophy of rugal folds):** Macroscopically, the disease presents with "cerebriform" enlargement of the gastric rugae (resembling brain gyri), primarily affecting the body and fundus while sparing the antrum [1]. **High-Yield Clinical Pearls for NEET-PG:** * **Clinical Triad:** Giant gastric folds + Hypoalbuminemia + Achlorhydria (due to parietal cell atrophy). * **Risk:** Associated with an increased risk of **Gastric Adenocarcinoma** in adults [1]. * **Pediatric Association:** In children, it is often transient and associated with **CMV infection** [1]. * **Treatment:** EGFR inhibitors (e.g., Cetuximab) are used in severe cases. **References:** [1] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. The Gastrointestinal Tract, pp. 775-776.

Question 212: Helicobacter pylori is implicated as a causative agent in which of the following conditions?

A. Hodgkin's Lymphoma
B. Non-Hodgkin's Lymphoma
C. MALT Lymphoma (Correct Answer)
D. Mantle cell Lymphoma

Explanation: **Explanation:** **1. Why MALT Lymphoma is Correct:** *Helicobacter pylori* is a Gram-negative, microaerophilic bacterium that causes chronic gastritis. Persistent infection leads to the recruitment of B-cells to the gastric mucosa, forming **organized lymphoid tissue** (which is normally absent in the stomach) [1]. Chronic antigenic stimulation by *H. pylori* triggers the proliferation of these B-cells, eventually leading to a monoclonal population known as **MALToma (Mucosa-Associated Lymphoid Tissue Lymphoma)**, a type of marginal zone B-cell lymphoma [1]. * **High-Yield Fact:** Gastric MALToma is unique because, in its early stages, it can be **cured or regressed** simply by eradicating the *H. pylori* infection with triple therapy. **2. Why Other Options are Incorrect:** * **A. Hodgkin’s Lymphoma:** This is characterized by Reed-Sternberg cells and is most commonly associated with the **Epstein-Barr Virus (EBV)**, not *H. pylori*. * **B. Non-Hodgkin’s Lymphoma (NHL):** While MALToma is a subtype of NHL, this option is too broad. In exams, always choose the most specific pathological entity. * **D. Mantle Cell Lymphoma:** This is an aggressive B-cell lymphoma characterized by the **t(11;14)** translocation and Cyclin D1 overexpression [2]. It is not linked to *H. pylori*. **3. NEET-PG Clinical Pearls:** * **Virulence Factors:** *H. pylori* uses **CagA** (Cytotoxin-associated gene A) and **VacA** (Vacuolating cytotoxin) to promote inflammation and carcinogenesis. * **Associated Malignancies:** *H. pylori* is a Class I Carcinogen associated with both **Gastric Adenocarcinoma** (Intestinal type) and **MALToma** [3]. * **Genetic Marker:** Advanced MALToma often involves the **t(11;18)(q21;q21)** translocation; cases with this translocation are usually resistant to antibiotic eradication therapy. **References:** [1] Cross SS. Underwood's Pathology: A Clinical Approach. 6th ed. Common Clinical Problems From Alimentary System Disease, pp. 356-357. [2] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Diseases of White Blood Cells, Lymph Nodes, Spleen, and Thymus, pp. 610-612. [3] Cross SS. Underwood's Pathology: A Clinical Approach. 6th ed. Common Clinical Problems From Alimentary System Disease, pp. 357-358.

Question 213: Which is the most common neoplasm of the appendix?

A. Lymphoma
B. Adenocarcinoma (Correct Answer)
C. Leiomyosarcoma
D. Argentaffinoma

Explanation: The classification of appendiceal neoplasms has historically been a subject of debate; however, according to the **current WHO classification and recent surgical pathology literature**, **Adenocarcinoma** (including its variants like mucinous adenocarcinoma) is considered the most common primary malignancy of the appendix. * **Why Adenocarcinoma is correct:** While "Carcinoid tumors" were traditionally cited as most common in older textbooks, modern epidemiological data and standardized reporting (especially when including Low-grade Appendiceal Mucinous Neoplasms or LAMNs under the adenomatous/adenocarcinoma spectrum) identify epithelial tumors—specifically Adenocarcinoma—as the most frequent primary neoplasm. * **Why Argentaffinoma is incorrect:** Argentaffinoma is an older term for a **Carcinoid tumor** (Neuroendocrine Tumor/NET) [2]. While NETs are common incidental findings in appendectomies, they are now generally ranked second to epithelial tumors in overall incidence [3]. * **Why Lymphoma is incorrect:** Primary gastrointestinal lymphoma of the appendix is extremely rare, accounting for less than 2% of appendiceal tumors [3]. * **Why Leiomyosarcoma is incorrect:** Mesenchymal tumors like leiomyosarcoma are exceptionally rare in the appendix. **High-Yield Clinical Pearls for NEET-PG:** * **Most common site for Carcinoid:** Small intestine (specifically distal ileum); the appendix is the second most common site [2]. * **Carcinoid Syndrome:** Rarely occurs with appendiceal carcinoids unless there are extensive liver metastases [1]. * **Pseudomyxoma Peritonei:** Most commonly arises from a ruptured **Mucinous Adenocarcinoma** or LAMN of the appendix ("Jelly Belly"). * **Clinical Presentation:** Most appendiceal neoplasms mimic **acute appendicitis** and are diagnosed post-operatively via histopathology. **References:** [1] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. The Gastrointestinal Tract, pp. 781-782. [2] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. The Gastrointestinal Tract, pp. 780-781. [3] Cross SS. Underwood's Pathology: A Clinical Approach. 6th ed. Common Clinical Problems From Alimentary System Disease, pp. 375-376.

Question 214: Which of the following conditions has the highest malignant potential?

A. Crohn's disease
B. Ulcerative colitis
C. Familial polyposis (Correct Answer)
D. Infantile polyp

Explanation: **Explanation:** The correct answer is **Familial Adenomatous Polyposis (FAP)**. This condition is characterized by an autosomal dominant mutation in the **APC gene** on chromosome 5q21, leading to the development of hundreds to thousands of adenomatous polyps throughout the colon [1]. **1. Why Familial Polyposis is correct:** FAP carries a **near 100% risk** of progressing to colorectal carcinoma, usually by age 40, if a prophylactic colectomy is not performed [1]. It follows the "adenoma-carcinoma sequence" where the sheer number of polyps makes malignant transformation statistically inevitable [1]. **2. Why the other options are incorrect:** * **Ulcerative Colitis (UC):** While UC significantly increases the risk of colorectal cancer (especially after 8–10 years of disease and with pancolitis), the cumulative risk is approximately 5–10% at 20 years—far lower than the 100% risk in FAP. * **Crohn’s Disease:** Similar to UC, it increases malignancy risk due to chronic inflammation, but the risk is generally considered lower than in UC and significantly lower than in FAP. * **Infantile (Juvenile) Polyp:** These are typically **hamartomatous polyps**, which are non-neoplastic and have no inherent malignant potential [2]. However, "Juvenile Polyposis Syndrome" (multiple polyps) does carry a risk, but a single sporadic infantile polyp does not [2]. **NEET-PG High-Yield Pearls:** * **Gardner Syndrome:** FAP + Osteomas (mandible) + Soft tissue tumors (Desmoid tumors). * **Turcot Syndrome:** FAP + CNS tumors (Medulloblastoma). * **Screening:** In FAP patients, annual sigmoidoscopy should begin at age 10–12 years. * **Malignancy Rule:** Among Inflammatory Bowel Diseases, the risk of cancer is higher in UC than in Crohn’s. **References:** [1] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. The Gastrointestinal Tract, pp. 821-822. [2] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. The Gastrointestinal Tract, p. 813.

Question 215: Tiger skin appearance of colonic mucosa is seen in which condition?

A. Melanosis coli (Correct Answer)
B. Ulcerative colitis
C. Environmental enteropathy
D. Carcinoid syndrome

Explanation: **Explanation:** **Melanosis coli** is the correct answer. This condition is characterized by a dark brown to black discoloration of the colonic mucosa, often described as a **"tiger skin," "leopard skin," or "alligator skin" appearance**. * **Pathophysiology:** It is caused by the chronic use of **anthraquinone laxatives** (e.g., senna, aloe, cascara). These substances cause apoptosis of colonic epithelial cells. The resulting apoptotic bodies are phagocytosed by macrophages in the *lamina propria*. * **Histology:** The dark pigment is actually **lipofuscin** (not melanin), stored within macrophages. It is a benign, reversible condition and is not associated with an increased risk of malignancy. **Why other options are incorrect:** * **Ulcerative colitis:** Characterized by diffuse mucosal inflammation, friability, and "pseudopolyps" [1]. In chronic cases, the colon may appear as a "lead pipe" due to loss of haustrations, but not tiger-skinned. * **Environmental enteropathy:** Primarily affects the small intestine (not colon), leading to villous atrophy and crypt hypertrophy, often seen in areas with poor sanitation. * **Carcinoid syndrome:** Associated with flushing, diarrhea, and right-sided heart failure. While carcinoid tumors can occur in the GI tract, they appear as firm, yellow submucosal nodules, not diffuse mucosal pigmentation. **High-Yield Pearls for NEET-PG:** * **Pigment:** Despite the name, the pigment is **Lipofuscin** (PAS positive), not melanin. * **Site:** Most prominent in the **cecum** and proximal colon. * **Association:** Strongly linked to **chronic constipation** and laxative abuse. * **Reversibility:** The appearance typically disappears within 6–12 months after stopping laxative use. **References:** [1] Cross SS. Underwood's Pathology: A Clinical Approach. 6th ed. Common Clinical Problems From Alimentary System Disease, pp. 367-368.

Question 216: Which of the following is the earliest change in the intestine that occurs in Crohn's disease?

A. Cobblestone appearance
B. Aphthous ulcer (Correct Answer)
C. Perforation
D. Stricture

Explanation: **Explanation:** In Crohn’s disease, the earliest macroscopic lesion is the **aphthous ulcer** [1]. These are small, shallow, punch-out ulcers that typically form over a lymphoid follicle (Peyer’s patch) [1]. As the disease progresses, these ulcers enlarge, coalesce, and extend deep into the wall to form linear, "serpentine" fissures [1]. **Analysis of Options:** * **Aphthous Ulcer (Correct):** This represents the initial stage of mucosal injury [1]. It is the precursor to the more extensive transmural inflammation characteristic of Crohn's. * **Cobblestone Appearance:** This is a **late/established feature**. It occurs when linear ulcers intersect, leaving islands of edematous, non-ulcerated mucosa between them. * **Stricture:** This is a **chronic complication** resulting from repeated cycles of transmural inflammation and subsequent fibrosis (healing by scarring), leading to luminal narrowing [1]. * **Perforation:** This is a **serious complication** of deep, penetrating ulcers. While Crohn’s is transmural, frank perforation is less common than in Ulcerative Colitis because the serosal inflammation often leads to adhesions or fistula formation first. **High-Yield NEET-PG Pearls:** * **Hallmark:** Transmural inflammation and **Non-caseating granulomas** (seen in 40-60% of cases) [1, 2]. * **Distribution:** "Skip lesions" (segmental involvement); most common site is the **terminal ileum** [1]. * **Radiology:** "String sign of Kantor" (due to strictures) and "Proud flesh" (separated bowel loops due to creeping fat) [1]. * **Microscopy:** Knife-like fissures and Paneth cell metaplasia. **References:** [1] Cross SS. Underwood's Pathology: A Clinical Approach. 6th ed. Common Clinical Problems From Alimentary System Disease, pp. 365-367. [2] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. The Gastrointestinal Tract, pp. 806-807.

Question 217: Mucosa associated lymphoid tumour (MALToma) is most commonly associated with which of the following microorganisms?

A. Candida albicans
B. Helicobacter pylori (Correct Answer)
C. Escherichia coli
D. Cytomegalovirus

Explanation: **Explanation:** **Mucosa-Associated Lymphoid Tissue (MALT) Lymphoma**, also known as extranodal marginal zone B-cell lymphoma, is most commonly associated with **Helicobacter pylori** infection in the stomach [1]. **Why H. pylori is correct:** The pathogenesis involves chronic antigenic stimulation. *H. pylori* infection triggers a persistent inflammatory response, leading to the recruitment of B-cells and the formation of acquired MALT in the gastric mucosa (which normally lacks lymphoid tissue) [1], [2]. Chronic stimulation leads to T-cell-dependent B-cell proliferation. Over time, genetic mutations (most commonly **t(11;18)(q21;q21)**) can occur, leading to monoclonal expansion and malignancy [3]. A hallmark of early-stage gastric MALToma is that it often **regresses completely** following the eradication of *H. pylori* with triple antibiotic therapy. **Why other options are incorrect:** * **Candida albicans:** A fungus primarily associated with oral thrush and esophagitis in immunocompromised patients; it does not cause lymphoid malignancy. * **Escherichia coli:** A normal commensal of the gut; while certain strains cause diarrhea or UTIs, it has no known association with gastric lymphomas. * **Cytomegalovirus (CMV):** Typically causes viral esophagitis or colitis in AIDS patients, characterized by "owl’s eye" intranuclear inclusions, but not MALToma. **High-Yield Clinical Pearls for NEET-PG:** * **Most common site:** Stomach (60%). * **Most common translocation:** **t(11;18)(q21;q21)** involving the *API2-MLT* gene. This translocation is a predictor of **resistance** to *H. pylori* eradication therapy. * **Microscopy:** Look for **lymphoepithelial lesions** (invasion of gastric glands by neoplastic B-cells). * **Other associations:** *Campylobacter jejuni* (IPSID/Immunoproliferative small intestinal disease), *Borrelia burgdorferi* (Skin MALT), and *Chlamydia psittaci* (Ocular adnexa MALT). **References:** [1] Cross SS. Underwood's Pathology: A Clinical Approach. 6th ed. Common Clinical Problems From Alimentary System Disease, pp. 356-357. [2] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. The Gastrointestinal Tract, p. 771. [3] Cross SS. Underwood's Pathology: A Clinical Approach. 6th ed. Common Clinical Problems From Alimentary System Disease, pp. 357-358.

Question 218: Crohn's disease is associated with polymorphisms in which gene?

A. NOD2/CARD 15 gene (Correct Answer)
B. P53 gene
C. Philadelphia chromosome
D. APC/Beta catenin

Explanation: **Explanation:** **Correct Option: A. NOD2/CARD 15 gene** Crohn’s disease (CD) is a chronic inflammatory bowel disease (IBD) characterized by a dysregulated immune response to gut microbiota. The most strongly associated genetic risk factor is a polymorphism in the **NOD2 gene** (also known as **CARD15**), located on chromosome 16 [1]. * **Mechanism:** NOD2 encodes an intracellular receptor that recognizes bacterial peptidoglycans [1]. Mutations lead to defective innate immune sensing, impaired secretion of antimicrobial peptides (defensins) by Paneth cells, and subsequent chronic mucosal inflammation. **Incorrect Options:** * **B. P53 gene:** Known as the "guardian of the genome," mutations in *TP53* are associated with a wide array of sporadic cancers and Li-Fraumeni syndrome, but not the primary pathogenesis of IBD. * **C. Philadelphia chromosome:** This refers to the t(9;22) translocation resulting in the *BCR-ABL1* fusion gene, which is the hallmark of Chronic Myeloid Leukemia (CML). * **D. APC/Beta catenin:** This pathway is central to the "Adenoma-Carcinoma Sequence" in colorectal cancer. Mutations in the *APC* gene are responsible for Familial Adenomatous Polyposis (FAP). **High-Yield Clinical Pearls for NEET-PG:** * **Genetics:** NOD2/CARD15 has the strongest association with **ileal** Crohn’s disease [1]. * **Morphology:** Look for "creeping fat," "cobblestone appearance," "string sign of Kantor" on imaging, and **non-caseating granulomas** (pathognomonic, present in ~35% of cases). * **Transmurality:** Unlike Ulcerative Colitis (mucosal), Crohn’s is **transmural**, leading to fistulas and strictures. * **Smoking:** Smoking is a risk factor for Crohn’s but is paradoxically protective in Ulcerative Colitis. **References:** [1] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Diseases of the Immune System, pp. 223-224.

Question 219: According to the Vogelstein adenoma carcinoma theory, which of the following genes are mutated in the development of colon cancer?

A. Beta catenin
B. K RAS
C. APC
D. All of the above (Correct Answer)

Explanation: The **Vogelstein Model**, also known as the **Adenoma-Carcinoma Sequence**, describes the stepwise progression of normal colonic epithelium to invasive carcinoma through the accumulation of specific genetic mutations. [3] ### **Explanation of the Correct Answer** The correct answer is **All of the above** because colon cancer development typically follows a predictable molecular timeline involving these three key genes: 1. **APC (Adenomatous Polyposis Coli):** This is the "gatekeeper" gene. Mutation or loss of the *APC* tumor suppressor gene is the **earliest event**, leading to the formation of a small adenoma. [1] 2. **$\beta$-catenin:** In the Wnt signaling pathway, APC normally degrades $\beta$-catenin. [2] When APC is mutated (or if $\beta$-catenin itself undergoes a gain-of-function mutation), $\beta$-catenin accumulates and translocates to the nucleus, promoting cellular proliferation. [1] 3. **K-RAS:** This is an oncogene. Mutations in *K-RAS* typically occur after APC loss, facilitating the growth and enlargement of the adenoma (transition from small to large adenoma). [1] ### **Why other options are included** While each option represents a distinct genetic hit, they are all integral components of the same pathway. The sequence concludes with the loss of additional tumor suppressor genes, most notably **TP53** (on chromosome 17p) and **DCC** (on chromosome 18q), which trigger the final conversion into invasive carcinoma. [3] ### **High-Yield Clinical Pearls for NEET-PG** * **Order of Mutations:** APC (First/Initiation) $\rightarrow$ K-RAS (Growth) $\rightarrow$ TP53/DCC (Invasion). [1] * **Chromosomal Instability (CIN) Pathway:** This Vogelstein sequence accounts for 80% of sporadic colorectal cancers. * **APC Gene Location:** Chromosome **5q21**. * **Morphological Correlation:** The transition from a "tubular adenoma" to "villous adenoma" and finally "carcinoma" mirrors these genetic hits. [3] **References:** [1] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. The Gastrointestinal Tract, p. 819. [2] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Neoplasia, pp. 304-305. [3] Cross SS. Underwood's Pathology: A Clinical Approach. 6th ed. Common Clinical Problems From Alimentary System Disease, pp. 373-374.

Question 220: What is the metabolic abnormality seen in large colorectal villous adenoma?

A. Hypochloremic metabolic alkalosis
B. Hypokalemic metabolic acidosis (Correct Answer)
C. Chloride-sensitive metabolic acidosis
D. Chloride-sensitive metabolic alkalosis

Explanation: **Explanation:** Large colorectal villous adenomas, particularly those located in the rectum, are known for their secretory activity. These tumors have a large surface area and are composed of frond-like projections that secrete significant amounts of **mucoid fluid** rich in proteins and electrolytes [1]. **1. Why Hypokalemic Metabolic Acidosis is Correct:** The secretory product of a villous adenoma contains high concentrations of **potassium** and **bicarbonate**. * **Hypokalemia:** The excessive loss of potassium-rich mucus leads to systemic potassium depletion. * **Metabolic Acidosis:** The loss of bicarbonate ($HCO_3^-$) in the stool results in a normal anion gap metabolic acidosis. This clinical triad (large villous adenoma, secretory diarrhea, and electrolyte depletion) is sometimes referred to as **McKittrick-Wheelock Syndrome**. **2. Why Incorrect Options are Wrong:** * **Options A & D (Metabolic Alkalosis):** Metabolic alkalosis typically occurs with upper GI loss (e.g., vomiting or gastric suctioning) where $H^+$ and $Cl^-$ are lost. Lower GI secretions are alkaline; thus, their loss leads to acidosis, not alkalosis [2]. * **Option C (Chloride-sensitive Acidosis):** While the acidosis is related to fluid loss, the primary driver is the loss of bicarbonate and potassium, not specifically a chloride-sensitive mechanism (a term more commonly associated with alkalosis patterns). **3. High-Yield Clinical Pearls for NEET-PG:** * **Villous Adenomas:** These have the **highest malignant potential** among all colonic polyps (up to 40-50%) [1]. * **Morphology:** They are often sessile, large, and look like "cauliflower" or "shaggy" velvet [1]. * **Clinical Presentation:** Patients may present with "pseudodiarrhea" (passage of large amounts of clear mucus) and signs of dehydration [1]. * **Rule of Thumb:** Remember—**"V"**illous is **"V"**illainous (most likely to become cancer and causes significant electrolyte "V"oiding). **References:** [1] Cross SS. Underwood's Pathology: A Clinical Approach. 6th ed. Common Clinical Problems From Alimentary System Disease, pp. 371-372. [2] Cross SS. Underwood's Pathology: A Clinical Approach. 6th ed. (Basic Pathology) introduces the student to key general principles of pathology, both as a medical science and as a clinical activity with a vital role in patient care. Part 2 (Disease Mechanisms) provides fundamental knowledge about the cellular and molecular processes involved in diseases, providing the rationale for their treatment. Part 3 (Systematic Pathology) deals in detail with specific diseases, with emphasis on the clinically important aspects., pp. 128-129.

Practice by Chapter

Oral Cavity and Esophageal Pathology

Practice Questions

Gastritis and Peptic Ulcer Disease

Practice Questions

Inflammatory Bowel Disease

Practice Questions

Malabsorption Syndromes

Practice Questions

Vascular Disorders of Intestine

Practice Questions

Diverticular Disease

Practice Questions

Intestinal Obstruction

Practice Questions

Gastrointestinal Infections

Practice Questions

Polyps and Neoplasms

Practice Questions

Appendiceal Pathology

Practice Questions

Want unlimited practice?

Get full access to all questions, explanations, and performance tracking.

Start For Free